Responsive Dual-Targeting Exosome as a Drug Carrier for Combination Cancer Immunotherapy

Recently, combination immunotherapy, which incorporates the activation of the immune system and inhibition of immune escape, has been proved to be a new powerful strategy for more efficient tumor suppression compared to monotherapy. However, the major challenge is how to integrate multiple immune dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yuanyuan, Zhou, Yingshun, Lu, Meng, Si, Haibin, Li, Lu, Tang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AAAS 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426567/
https://www.ncbi.nlm.nih.gov/pubmed/34541546
http://dx.doi.org/10.34133/2021/9862876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426567/
https://www.ncbi.nlm.nih.gov/pubmed/34541546
http://dx.doi.org/10.34133/2021/9862876

Ejemplares similares